Publication: EAACI guidelines on the management of IgE-mediated food allergy
Program
KU-Authors
Büyüktiryaki, Ayşe Betül
KU Authors
Co-Authors
Santos A.F., Riggioni C., Agache I., Akdis C.A., Akdis M., Alvarez-Perea A., Alvaro-Lozano M., Ballmer-Weber B., Barni S., Beyer K., Bindslev-Jensen C., Brough H.A., Chu D., Del Giacco S., Dunn-Galvin A., Eberlein B., Ebisawa M., Eigenmann P., Eiwegger T., Feeney M., Fernandez-Rivas M., Fiocchi A., Fisher H.R., Fleischer D.M., Giovannini M., Gray C., Hoffmann-Sommergruber K., Halken S., O'B Hourihane J., Jones C.J., Jutel M., Knol E.F., Konstantinou G.N., Lack G., Lau S., Mejias A.M., Marchisotto M.J., Meyer R., Mortz C.G., Moya B., Muraro A., Nilsson C., de Oliveira L.C.L., O'Mahony L., Papadopoulos N.G., Perrett K.P., Peters R., Podesta M., Poulsen L.K., Roberts G., Sampson H., Schwarze J., Smith P., Tham E., Untersmayr E., Van Ree R., Venter C., Vickery B., Vlieg-Boerstra B., Werfel T., Worm M., Du Toit G., Skypala I.
Advisor
Publication Date
Language
Type
Journal Title
Journal ISSN
Volume Title
Abstract
This European Academy of Allergy and Clinical Immunology (EAACI) guideline provides recommendations for the management of IgE-mediated food allergy and was developed using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) approach. Following the confirmation of IgE-mediated food allergy diagnosis, allergen avoidance and dietary advice (with support of a specialised dietitian, if possible) together with the provision of a written treatment plan, education on the recognition of allergic symptoms and prescription of medication including adrenaline using an auto-injector are essential. Patients with significant anxiety and requirement for coping strategies may benefit from support from a clinical psychologist. As immunomodulatory interventions, omalizumab is suggested for treatment of IgE-mediated food allergy in children from the age of 1 and adults;and oral allergen-specific immunotherapy is recommended for children and adolescents with peanut allergy and suggested for milk and egg allergies (generally after 4 years of age for milk and egg). Sublingual and epicutaneous immunotherapy are suggested for peanut allergy but are not yet available at the point of care. Future research into disease modifying treatments for IgE-mediated food allergy are highly needed, with standardised and patient-focused protocols and outcomes. © 2024 The Author(s). Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley and Sons Ltd.
Source:
Allergy: European Journal of Allergy and Clinical Immunology
Publisher:
John Wiley and Sons Inc
Keywords:
Subject
Medicine